Nicholas Pajewski

I’m a biostatistician working in clinical trials, particularly in older adults. Most other moments I try to be on the golf course,

[Jennifer Gabbard @Docgabby35]

I can’t believe I’ve been selected for the Early Career Investigator Award by @AAHPM ! 🎉 A heartfelt thank you to my amazing mentors, supportive patients and families, and our dedicated palliative care team for making this possible. Feeling honored! 🙏 #AAHPM #PalliativeResearch

[Robert Howard @ProfRobHoward]

Looking for a version of the MoCA that can be administered over the phone and was reminded of the Impossible MoCA, which is always fun to give to anxious colleagues. "Just a standard test I give to all my patients".

[Kevin Sheth @sheth_kevin]

🚀 Join Yale's Cutting-Edge Brain & AI Research Team! 🧠✨

Yale's Center for Brain & Mind Health (CBMH) is hiring at all levels to lead innovative AI-driven neuroscience! We're seeking passionate researchers applying AI to brain health challenges. Don’t miss the chance to shape the future of clinical neuroscience in a highly collaborative, inclusive environment! Apply now and push the frontiers of brain science. 🌍💡

🔗 Apply here: https://t.co/nBskZijZyg

#AI #BrainHealth #Neuroscience #Yale #Innovation #NeuroAI #FacultyPosition #DiversityAndInclusion

[Eric Widera, MD @EWidera]

NIA’s now ex-neuroscience division director falsified/fabricated study results... results that led to clinical trials of the antibody prasinezumab which had no effect on global or imaging measures of Parkinson’s disease progression in a 2022 NEJM paper
https://t.co/jLkGSy8GRF

[Yale School of Medicine @YaleMed]

Patients with #Alzheimers disease and #hypertension have an even greater risk of cognitive decline than those with one #riskfactor and not the other, according to a new @AlzDemJournals study led by @NeurologyYale's Adam de Havenon, MD: https://t.co/QTmhJkbpZI

[Stephanie Parks Taylor @StephptaylorCLT]

Want to know more about facilitators and barriers to implementation of a Sepsis Transition and Recovery program? A report of our pre-implementation work is now published ⁦@HSRatBMC⁩
Congrats to ⁦@TaraEatonPhD⁩ and team! https://t.co/Fa4Qh5qDkq

[Sandra Shi @shisadoctor]

Frailty in Medicare Advantage and Traditional Medicare Beneficiaries https://t.co/PVCTx8DO2g

[Eric Widera, MD @EWidera]

For every study that helps us decide whether to start a new medication, there should be an equal & opposite study to help us decide when to stop a medication. With that new law of medicine, I present you this study on beta-blocker discontinuation after MI
https://t.co/A4QSC6Unxo

[Eric Widera, MD @EWidera]

Every Target Trial Emulation Study: "Randomization was emulated using propensity score matching adjusting for baseline covariates"

Narrator: this was an observational study where nothing close to randomization was done

[Manjula Kurella Tamura @ManjulaKTamura]

In my advanced CKD clinic, this is a common clinical encounter: Mr. Jones is 83 and has chronic kidney failure with a low eGFR. He’s not eligible for a transplant.

[Thavone Khounthikoumane @khounthikoumane]

🎓 Join Our Team! 🎓 @wakeforestmed is seeking a talented researcher for an open rank, tenure track position in Geroscience. If your work explores the biology of aging and chronic disease, we’d love to hear from you!
💼 Apply now: https://t.co/Pqlc27yY4q

@agingup @toddhaberkost

[Nicholas Pajewski @NMPajewski]

@Jeff_Browndyke @RenegadeSynapse @MemoryDoc @MicieliA_MD Thanks @RenegadeSynapse. Would love to pool some more representative data into this at some point to make it better. But totally agree, better than the 22 vs 25 vs 26 garbage.

[JASN_News @JASN_News]

SPRINT showed that intensive lowering of systolic BP increased the risk of incident CKD and episodes of AKI. A study looked at legacy effect of intensive vs. standard systolic BP lowering on longer-term incidence of kidney failure. Rates of dialysis or transplantation were higher with intensive treatment, but differences were small https://t.co/XX0xO30zny

[Nrupen Bhavsar @Nrupen]

Great work by @priyapalta

[Public Health, Equity & Human Flourishing @PHEHF_TUA]

The relationship between frailty and social vulnerability: a systematic review - The Lancet Healthy Longevity https://t.co/30TOLUP9Zx @TorrensUni @TheLancet @ElsaDent

[Christopher A. Longhurst, MD @CALonghurst]

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥 𝐞𝐧𝐫𝐨𝐥𝐥𝐦𝐞𝐧𝐭? 📊

Learn how @UCSDHealth investigators consented and scheduled over 2000 clinical trial participants in less than 4 weeks (!) at low cost by integrating workflows in a vendor EHR! A short 🧵 (1/4)

[Stephen Juraschek MD, PhD, FAHA, AHSCP-CHS @spjuraschek]

Really nice article on the importance of hypertension control. Thank you @ACPIMPhysicians for featuring our work!
Continue BP control, maintain benefits | I.M. Matters from ACP https://t.co/rnkgBnj2Ht

[William Schpero @wschpero]

🚨Federal claims data are critical to efforts to improve spending, quality, and equity in our health care system.

In @JAMA_current, we wrote about how @CMSGov's data policy change may compromise these efforts — and recommended a better path forward.

https://t.co/TQOUHsBweK

1/N

[Aditi Gupta @AditiGuptaKUMC]

Improvement in cognitive function after kidney transplantation @KUJGKI @KUNeph @KUALZ

[Ariela Orkaby MD MPH @DrAROrkaby]

Thank you @GeriPalBlog for the opportunity to discuss eFIs together with my wonderful colleagues @KateCallahanMD and @DaeKimMD. Check out https://t.co/IddQGvxt8b - a new resource to help guide clinical frailty assessments!